.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

COVID-19
Sickle Cell Disease

ClinicalSee All >

ADHD
Allergy
Arterial Disease
Cardiology
Dermatology
Diabetes
Gastroenterology
Geriatric Medicine
Infectious Disease
Inflammation
Insomnia
Neurology
Psychiatry
Pulmonology
Rheumatology

Video Series

Insights
News Network
Peers & Perspectives
Post Conference Perspectives

About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions

Optimal Management of Rheumatic Disease During COVID-19

EP. 1: Rheumatic Disease Challenges and Goals of Therapy

December 7th 2020

EP. 2: Psoriatic Arthritis Treatment Factors: Comorbidities

December 7th 2020

EP. 3: Data on COVID-19 in Patients With Rheumatic Disease

December 7th 2020

EP. 4: IL-6 Receptor Blockade in ICU Patients With COVID-19

December 7th 2020

EP. 5: Treatment Modification: ACR COVID-19 Guidelines

December 7th 2020

EP. 6: Accurately Diagnosing Psoriatic Arthritis

December 7th 2020

EP. 7: Guselkumab for Psoriatic Arthritis

December 7th 2020

EP. 8: Deucravacitinib for Active Psoriatic Arthritis

December 7th 2020

EP. 9: Treating Enthesitis in Psoriatic Arthritis Patients: Filgotinib

December 7th 2020

EP. 10: SELECT-PsA 1 and SELECT-PsA 2 in Psoriatic Arthritis

December 7th 2020

Latest News

Greater Baseline Retinal Nonperfusion Linked to Worsening Diabetic Retinopathy

John J. Miller, MD: A New Era For Psychiatric Medications

Aluminum Exposure Induces Cytokine Secretion in Crohn’s Disease Colons

View More News